Urology

SRI has extensive experience in urology, conducting research across multiple key indications and diseases. Our expertise includes Benign Prostate Hyperplasia (BPH), Erectile Dysfunction (ED), Overactive Bladder (OAB), and Urinary Tract Infection (UTI). In addition, SRI works in urologic oncology, covering prostate cancer, bladder cancer, and rare urologic cancers, as well as nephrology areas such as proteinuria, nephritis associated with other diseases, and renal cell carcinoma. This broad therapeutic focus supports comprehensive market research and strategic insights in the urology field.

SRI’s project types cover a wide spectrum, including patient and physician qualitative and quantitative research, market access and competitive landscape analysis, treatment pathway and patient journey studies, segmentation, and demand forecasting. This comprehensive experience enables SRI to deliver actionable strategic insights that support product development, launch, and lifecycle management in urology.